A Double-Blind, Randomized, Multi-Center, Flexible Dose Study Evaluating the Efficacy and Safety of SPD503 (Guanfacine Hydrochloride) in Children Aged 6-12 With Symptoms of Oppositionality and a Diagnosis of Attention Deficit/Hyperactivity Disorder
收藏DataCite Commons2025-01-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008006/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjects with ADHD and
oppositional symptoms.
提供机构：
Vivli
创建时间：
2022-06-23
